Emergence or reemergence seen in which of the following organisms –
**Core Concept**
The question is testing the concept of antimicrobial resistance, specifically the emergence or reemergence of certain microorganisms due to genetic mutations or changes in their environment. This is a crucial aspect of infectious disease management, as it can lead to treatment failures and outbreaks.
**Why the Correct Answer is Right**
The correct answer is associated with the reemergence of Mycobacterium tuberculosis, a bacterium that causes tuberculosis (TB). This has been attributed to the development of drug-resistant strains, particularly multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB). The emergence of these strains is due to the misuse and overuse of antibiotics, as well as the natural genetic variability of M. tuberculosis. The bacteria can develop resistance through mutations in genes encoding for drug targets, such as the rpoB gene, which codes for the beta-subunit of RNA polymerase.
**Why Each Wrong Option is Incorrect**
* **Option A:** This is incorrect because the emergence of antibiotic-resistant Staphylococcus aureus, while a significant public health concern, is not the primary example of reemergence in this context.
* **Option B:** This is incorrect because the reemergence of Plasmodium falciparum, the parasite that causes malaria, is more related to changes in human behavior and environmental factors rather than antimicrobial resistance.
* **Option C:** This is incorrect because the emergence of Clostridioides difficile, a bacterium that causes diarrhea and colitis, is more related to changes in the human microbiome and antibiotic use rather than reemergence of a previously controlled disease.
**Clinical Pearl / High-Yield Fact**
The reemergence of M. tuberculosis highlights the importance of infection control measures, such as proper ventilation and contact tracing, to prevent the spread of TB. Additionally, the development of new diagnostic tools and treatments, such as bedaquiline and delamanid, has improved outcomes for patients with MDR-TB and XDR-TB.
**Correct Answer:** C.